Publications

Fisher H, East A, Vallero D. Estimating longitudinal aggregate exposure — The third module of CHEM: Source to dose. Symposium presented at International Society of Exposure Science Annual Meeting, virtual conference, September 2021, DOI: 10.23645/epacomptox.16630675, open access online.

Wikoff D, Fitch S, Borghoff S. Case-study applications using evidence-based approaches to assess endocrine activity for risk assessment. Invited speaker (Wikoff):  61^st Annual Meeting (virtual) of the Society for Birth Defects Research & Prevention, June 2021.

Dougherty C., Friedman BW, Aurora S, Bariahtaris S, Shrewsbury S, Baker-Wagner M, Sacks N, Kautz S, Cyr P. Impact of INP104 on healthcare resource use among patients in STOP 301. Presentation at American Academy of Neurology annual meeting [held virtually], April 2021.

Dougherty C., Friedman BW, Aurora S, Bariahtaris S, Shrewsbury S, Baker-Wagner M, Sacks N, Kautz S, Cyr P. INP104 reduces self-reported ED and urgent care in patients with episodic migraine. Presentation at Academy of Managed Care Pharmacy (AMCP) annual meeting [held virtually], April 2021.

Sheshadri A, Sacks NC, Healey B, Raza S, Boerner G, Huang HJ. A descriptive analysis of costs and healthcare resource use in patients with bronchiolitis obliterans syndrome (BOS) following LUNG transplantation. Poster presentation, ISPOR, May 2021.

Wallace E, Sacks NC, Cyr P, Baker-Wagner M. An observational cohort analysis on the economic impact of chronic kidney disease in patients with fabry disease. Poster presentation, ISPOR, May 2021.

Sacks NC, Healey B, Cyr PL, Slocomb T, James E, Beggs A, Graham RJ. Healthcare resource use and expenditures in patients with x-linked myotubular myopathy (XLMTM). Poster presentation, ISPOR, April 2021.

Panattoni L, Hernandez J, Liu Y, Sacks NC, Higham R, Stephenson B, Armstrong A. Initial treatment patterns for newly diagnosed, commercially insured patients with psoriasis. Poster presentation, ISPOR, April 2021.

Wikoff D. The [acceptable daily intake] for low- and no-calorie sweeteners: Origin, interpretation, and application. Invited speaker: Continuing education webinar, Institute for the Advancement of Food and Nutrition Sciences, July 2021.

Suh M, Movva N, Bylsma L, Demont C, Rizzo C, Fryzek J, Nelson CB. Systematic literature review (SLR) of respiratory syncytial virus (RSV) burden and health care utilization (HCU) among infants in the United States (US). Poster presentation [preview] at 37^th ICPE (International Conference on Pharmacoepidemiology & Therapeutic Risk Management), virtual conference, August 2021.

Rivera BN, Rohlman D, Anderson K, Tilton S. Chemical mixtures: What we know and where the field is headed. Northwest Toxics Community Coalition Virtual Summit, April 2021.

Broome, C, Patel P, Jiang X, Iglesias-Rodriguez M, Fryzek J. Increased antidepressant use among newly diagnosed patients with cold agglutinin disease compared with other patients in a large US healthcare system. E-poster presentation to European Hematology Association Virtual Congress, June 2021.

Broome CM, Patel P, Jiang X, Iglesias-Rodriguez M, Fryzek J. Increased antidepressant use among newly diagnosed patients with cold agglutinin disease compared with other patients in a large US healthcare system. Poster presentation to European Hematology Association Congress (Abstract EP1180), June 2021, online.

Vágó EK, Nicholson G, Horváth-Puhó E, Hooda N, Fryzek JP, Su J. Healthcare resource utilization among patients with cold agglutinin disease in Denmark. Poster presentation to European Hematology Association Congress (Abstract EP1193), June 2021, online.

Gillezeau C, Movva N, Fryzek J, Rabon-Stith K, Brohawn PZ, Gerwen M van, Taioli E. Molecular epidemiology study of interferon gamma (IFN-γ) expression in urothelial bladder cancer (UBC). Poster presentation [preview] at 37^th ICPE (International Conference on Pharmacoepidemiology & Therapeutic Rick Management), virtual conference, August 2021.

Bylsma L, Nielson C, Fryzek J, Saad H, Crawford J. Edit chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis. Poster presentation [preview] at 37^th ICPE (International Conference on Pharmacoepidemiology & Therapeutic Rick Management), virtual conference, August 2021.

Vágó EK, Nicholson G, Horváth-Puhó E, Hooda N, Fryzek J, Su J. Healthcare resource utilization among patients with cold agglutinin disease in Denmark. E-poster presentation to European Hematology Association Virtual Congress, June 2021.

Pangburn HA, Linakis MW, Chushak YG, Covington TR, McCarthy MJ, Gearhart JM. New approach methodologies informing operational Air Force mission. Presentation at the Society of Toxicology Annual Meeting, virtual event, March 2021.

O’Neil HC, Vincent MJ, Han AA, Brown SE, Hazell AM, Krieder ML, Madl AM. Hazard and risk banding framework for prioritization and bridging of e-liquids for toxicity testing. Poster presented at Society of Toxicology Annual Meeting, virtual event, March 2021.

Buerger AN, Boles C, Reichard J, Fung E, Dahm C, Schmid K, et al. A framework for establishing occupational exposure limits for medicinal enzymes. Poster presented at Society of Toxicology Annual Meeting, virtual event, 2021.